Fast Facts : CAR T-cell therapy in diffuse large B-cell lymphoma : a practical resource for nurses /

Diffuse large B-cell lymphoma (DLBCL) is the most common form of high-grade non-Hodgkin lymphoma. While treatment with immunochemotherapy has generally shown good outcomes, specific subgroups of patients with high-risk disease have an unfavorable prognosis. Extensive efforts have been made to improv...

Ausführliche Beschreibung

Gespeichert in:
Weitere Titel:
CAR T-cell therapy in diffuse large B-cell lymphoma
Hauptverfasser:
Buka, R. J., Moloney, Deirdre
Format:
Elektronisch E-Book
Sprache:
Englisch
Veröffentlicht:
Abingdon, Oxford : S. Karger Publishers Ltd, 2021.
Ausgabe:
1st ed.
Zusammenfassung:
Diffuse large B-cell lymphoma (DLBCL) is the most common form of high-grade non-Hodgkin lymphoma. While treatment with immunochemotherapy has generally shown good outcomes, specific subgroups of patients with high-risk disease have an unfavorable prognosis. Extensive efforts have been made to improve outcomes in these patients. As such, CD19-targeted chimeric antigen receptor (CAR) T-cell therapy has become the new standard of care for patients with relapsed or refractory DLBCL after at least two prior lines of therapy. It is an exciting new therapeutic intervention that is integral to the concept of personalized medicine.Table of Contents:•DLBCL: an overview•CAR T cells•CAR T-cell products•Delivering CAR T-cell therapy and managing patient expectations•CAR T-cell therapy-related toxicities
Umfang:
1 online resource (93 pages) : color illustrations
Anmerkungen:
R2 Digital Library does not include index.
Anmerkungen:
Text in English
Bibliografie:
Includes bibliographical records and index.
ISBN:
3-318-06935-3
Schlagworte:
B cells > Tumors > Treatment.
T cells.
Cancer > Nursing.
Lymphoma, Large B-Cell, Diffuse > therapy.
Receptors, Chimeric Antigen > therapeutic use.
Immunotherapy, Adoptive > methods.
Immunotherapy, Adoptive > adverse effects.
Oncology Nursing.
Bezugswerke:
Links: